Clinical Trial Update: Safety and Pharmacodynamic Study of CD-NP [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacodynamic study of CD-NP in heart failure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CD-NP (CD-NP)

Snippet

Sponsor: Nile Therapeutics | Conditions: Heart Failure, Congestive | Phase 1 | Status: COMPLETED